Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors

被引:0
|
作者
Dziadkowiec, Karolina [1 ]
Stawinski, Peter [1 ]
Proenza, Jose [1 ]
机构
[1] Univ Miami, JFK Med Ctr Palm Beach, W Palm Beach, FL USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1615
引用
收藏
页码:S726 / S727
页数:2
相关论文
共 50 条
  • [1] Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors
    Dziadkowiec, Karolina N.
    Stawinski, Peter M.
    Proenza, Jose
    ACG CASE REPORTS JOURNAL, 2021, 8 (01)
  • [2] Consideration for Empagliflozin-associated Pancreatitis
    Lightbourne, Taber
    Najafian, Nilofar
    McCarty, Thomas R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S710 - S710
  • [3] Empagliflozin-Associated Pancreatitis in the Setting of Hyperglycemic Hyperosmolar Syndrome
    Borrelli, Jenna C.
    Cioffi, Martine A.
    Martini, Nora
    Samarneh, Mark
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [6] Risks Associated with SGLT2 Inhibitors: An Overview
    Singh, Mahakpreet
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2018, 13 (02) : 84 - 91
  • [7] Empagliflozin-Associated Fournier Gangrene
    Ubaid, Aamer
    Naeem, Awais
    Waheed, Farishta
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E495 - E497
  • [8] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [9] SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice
    Lee, Ye-Eul
    Im, Dong-Soon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [10] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39